Article Details
Retrieved on: 2024-11-21 18:22:16
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
("Alto Neuroscience" or "the Company") (NYSE:ANRO) for violations of the securities laws. The investigation focuses on whether the Company issued ...
Article found on: markets.businessinsider.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here